Patrick Phelps2025-10-13T13:31:06+00:00Trilantic North America Completes Strategic Growth Investment in SOFIE BiosciencesPatrick Phelps2025-10-13T13:31:06+00:004, Jun 2024|
Patrick Phelps2025-10-15T16:42:11+00:00[18F]FAPI-74 serving as complementary diagnostic in Avacta Phase 1 trialPatrick Phelps2025-10-15T16:42:11+00:0023, May 2024|
Patrick Phelps2025-10-15T16:42:14+00:00SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET RadiotracersPatrick Phelps2025-10-15T16:42:14+00:0011, Oct 2023|
Patrick Phelps2025-10-15T16:42:11+00:00FAP symposium another success at 2023 SNMMI meetingPatrick Phelps2025-10-15T16:42:11+00:007, Jul 2023|
sofie_c557hm2025-10-13T13:46:01+00:00RLS and SOFIE Enter Strategic Partnership for Distribution of Nuclear Medicine Doses for Patientssofie_c557hm2025-10-13T13:46:01+00:0021, Jun 2023|
Patrick Phelps2025-10-15T16:42:11+00:00SOFIE partners with BAMF Health, diversifying sites for Phase II [68Ga]FAPI-46 studyPatrick Phelps2025-10-15T16:42:11+00:006, Jun 2023|
